Yayın:
Changes of plasma free choline and choline-containing compounds' concentrations and choline loss during hemodialysis in ESRD patients

Placeholder

Tarih

Akademik Birimler

Kurum Yazarları

Özarda, Yeşim
Dilek, Kamil
Yurtkuran, Mustafa Abbas
Ulus, İsmail Hakkı

Yazarlar

Danışman

Dil

Türü

Yayıncı:

Pergamon-Elsevier Science

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Objectives: This study was undertaken to determine the changes in plasma free choline and choline-containing compounds in end stage renal disease (ESRD) and to determine if they were lost into the dialysate during hemodialysis. Design and methods: Plasma and dialysate free choline, phosphocholine and phospholipid, phosphatidylcholine-, sphingomyelin-bound choline were measured before, during and after hemodialysis. Results: Plasma free and bound choline concentrations (mean +/- standard error of the mean) were 12.9 +/- 0.6 and 2697 +/- 57 muM or 37.3 +/- 0.9 and 2792 +/- 98 muM in controls or in ESRD patients, respectively. Free choline concentrations were correlated (r = 0.598 p < 0.001) with the time the patients were subjected to hemodialysis. Plasma free choline and phosphocholine concentrations a-re decreased by a total of -8.1 +/- 0.6 μmol/L and -88 +/- 8 μmol/L, respectively: phospholipid- phosphatidylcholine- and sphingomyelin-bound choline are increased, during hemodialysis. Patients lost about 350 μmoles of choline into the dialysate during hemodialysis. Conclusion: Plasma free choline concentrations are elevated in ESRD. and a considerable amount of choline is lost into the hemodialysate.

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Choline, Sphingomyelin, Phosphocholine, Phosphatidylcholine, End stage renal disease, Hemodialysis, Rat Corpus Striatum, Acetylcholine-release, Parenteral-nutrition, Tyrosine-hydroxylase, Brain phospholipids, Deficiency, Cytidine, Neurons, Liver

Alıntı

Özarda, Y. vd. (2002). "Changes of plasma free choline and choline-containing compounds' concentrations and choline loss during hemodialysis in ESRD patients". Clinical Biochemistry , 35(3), 233-239.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads